First we tested 2 different shRNAs that efficiently knock down FBXL10 (Supplementary Fig. S2a) in selected DLBCL cell lines (OCI-Ly1, SU-DHL-16, TMD8 and U2932). This evidence concerns the gene KDM2B and diffuse large B-cell lymphoma.